PDCD1 and neoplasm: Lymphocytes and tumor-infiltrating CD8+T cells were extracted from tumor tissues of tumor-bearing mice and treated with anti-PD1 antibody combined with different dosage anti-VEGFR2 antibody (DC101) in vitro.